Concepedia

Author

Kaori Hamada

Astellas Pharma (Japan)

Also Known As

Kaori Hamada

18

Publications

350

Citations

11

H-Index

24

Concepts

All Affiliations

Astellas Pharma (Japan)Fujisawa City HospitalThe University of Tokyo
KH

About

Kaori Hamada is an author at Astellas Pharma (Japan) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

91

2

Pharmacology

4

4

56

3

Public Health

1

1

15

4

Anesthesia

1

1

15

5

Biochemistry

1

1

11

Kaori Hamada

×

11

Publications

230

Citations

10

H-Index

YearCitations

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β<sub>3</sub>-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Masashi Imanishi, Yasuyo Tomishima, Shinji Itou,

Journal of Medicinal Chemistry

2008

41

Shortening of Action Potential Duration is not Prerequisite for Cardiac Protection by Ischemic Preconditioning or a KATPChannel Opener

Kaori Hamada, Jun Yamazaki, Taku Nagao

Journal of Molecular and Cellular Cardiology

1998

35

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Masashi Imanishi, Shinji Itou, Kenichi Washizuka,

Journal of Medicinal Chemistry

2008

30

Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model

Kazuya Nagata, Tomio Sasaki, Junichi Iwama,

Journal of neurosurgery

1993

24

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β<sub>3</sub>Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Masashi Imanishi, Yutaka Nakajima, Yasuyo Tomishima,

Journal of Medicinal Chemistry

2008

21

FR226807: a potent and selective phosphodiesterase type 5 inhibitor

Naomi Hosogai, Kaori Hamada, Masayuki Tomita,

European Journal of Pharmacology

2001

19

Shortening of Monophasic Action Potential Duration During Hyperkalemia and Myocardial Ischemia in Anesthetized Dogs

Kaori Hamada, Jun Yamazaki, Taku Nagao

The Japanese Journal of Pharmacology

1998

15

Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure

Masayuki Tomita, Hajime Sogabe, Shoko Nakazato,

Nephrology Dialysis Transplantation

2005

13

The Pharmacological Characterization of FK 739, a New Angiotensin II-Receptor Antagonist

Kaori Hamada, Yoshimitsu Nakajima, Hisataka Nirei,

The Japanese Journal of Pharmacology

1993

11

Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6

Kouji Hattori, Masaya Orita, Susumu Toda,

Bioorganic & Medicinal Chemistry Letters

2009

11

Page 1